Proteina Company Description

Proteina Co.,Ltd. develops protein-protein interaction profiling technology.

The company offers technology that confirms the real-time activation of cancer signal pathways by directly seeing the relevant proteins, predicts the efficacy of drugs, and enables doctors to select which inhibitor to prescribe by confirming which bypass signal pathways are inducing resistance.

It also offers single molecule protein interaction detection platform to analyze protein and protein-protein interaction (PPI) information.

Proteina Co., Ltd. was founded in 2015 and is based in Seoul, South Korea.

Proteina Co., Ltd.

Country	South Korea
Founded	2015
Industry	Biotechnology
Sector	Healthcare
CEO	Tae-Young Yoon

Contact Details

Address: Ace Techno Tower 8 #1301 Seoul, 08380 South Korea
Phone	82 2 6959 9309
Website	proteina.co.kr

Stock Details

Ticker Symbol	468530
Exchange	KOSDAQ
Reporting Currency	KRW
ISIN Number	KR7468530001
SIC Code	2836

Key Executives

Name	Position
Tae-Young Yoon	Chief Executive Officer
Dai Seung Lee	Chief Financial Officer
Steve Hwang	Head of Investor Relations